Friday, August 09, 2019 3:55:27 PM
Net sales rose 18.8% to $5.3 million. Second quarter in a row of record earnings. Expect earnings growth to accelerate as Grifols Xembify sales beginning to kick in during 2020. Management believes Xembify sales to be additive and will not cannibalize existing sales.
Gross margin improved to 65.0% Expect gross margins to continue improving with future sales growth and production efficiencies. Production efficiencies are like an annuity that keep paying benefits quarter after quarter.
The company has no debt and $3.8 million of cash and cash equivalents.
The above are a few of the reason I see this as a safe growth stock scenario.
Do your own DD.
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM